Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Hip Surgery
NCT03938831Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- May 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Incidence of Postoperative Delirium at 2 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03938831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03938831.